Urinary Incontinence: Clinical Trials

133 trials for Urinary Incontinence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

95 completed, 14 unknown, 11 terminated, 8 withdrawn. 133 Phase 3, 18 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3133Completed 95, Unknown 14, Terminated 11, Withdrawn 8, Active not recruiting 3, Recruiting 2
Phase 218Completed 11, Unknown 3, Withdrawn 2, Active not recruiting 1, Terminated 1

Follow Urinary Incontinence: new trials by email Literature Review of Urinary Incontinence trials Research Report on Urinary Incontinence

Trials (filtered) newest first · largest first

All 133 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Orforglipron, Placebo - Urinary Incontinence,Stress
Phase 3RecruitingEli Lilly and Company10002025-09-302026-11-04
COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis
Diaper with a copper-based product + usual care, Barrier product with common diaper - Incontinence-associated Dermatitis
Phase 2 / Phase 3WithdrawnHospital Israelita Albert Einstein2025-09-012026-01-12
Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1)
AMDC-USR, Placebo - Stress Urinary Incontinence
Phase 3WithdrawnCook MyoSite2025-06-012024-08-27
Pivotal Study of Voro Urologic Scaffold
Voro Urologic Scaffold - Radical Prostatectomy, Stress Urinary Incontinence (SUI)
Phase 3Active not recruitingLevee Medical, Inc.2662025-04-182026-09-30
Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)
Solifenacin, Mirabegron - Urinary Incontinence in Children
Phase 3RecruitingUniversity of Aarhus2362024-06-272026-06-08
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
OnabotulinumtoxinA - Urinary Incontinence, Overactive Bladder Syndrome
Phase 2 / Phase 3Active not recruitingNorthwestern University662023-07-132026-11-06
BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy
BioDFence G3 - Prostate Cancer, Prostatectomy
Phase 3WithdrawnAdventHealth2023-04-012023-06-29
Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery
Bupivacaine-Meloxicam - Stress Urinary Incontinence, Surgical Incision
Phase 3CompletedTriHealth Inc.1482023-01-232024-11-22
The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder
Alkalinized Lidocaine, Placebo Sodium Chloride 0.9% Inj - Urge Incontinence, Overactive Bladder
Phase 3UnknownHerlev and Gentofte Hospital502022-09-122022-09-22
Lidocaine for Pessary Check Pain Reduction
Lidocaine Hcl 2% Jelly, Placebo Jelly - Pelvic Organ Prolapse, Stress Urinary Incontinence
Phase 3CompletedUniversity of South Florida662022-09-082023-12-14
Platelet-Rich Plasma for Stress Urinary Incontinence
Platelet-rich plasma injection - Urinary Incontinence,Stress, Urinary Incontinence
Phase 3CompletedAnnah J. Vollstedt502022-05-232024-08-29
Platelet Rich Plasma in Women With Urinary Incontinence
Platelet Rich Plasma Injections, Normal Saline Injections - Urinary Incontinence, Stress Urinary Incontinence
Phase 2 / Phase 3UnknownNational and Kapodistrian University of Athens502021-07-012021-11-09
Testosterone Effects on Pelvic Floor Muscles
Testosterone Enanthate, Placebo - Urinary Incontinence, Menopause
Phase 3WithdrawnBrigham and Women's Hospital2021-01-012022-07-20
Sling vs Botox for Mixed Incontinence
Botox® injection, Mid-urethral sling - Urinary Incontinence, Stress, Urinary Incontinence, Urge
Phase 3CompletedNICHD Pelvic Floor Disorders Network1502020-06-082025-06-03
Comparisons of the Impact of Duloxetine Versus Imipramine on Therapeutic Efficacy, Psychological Distress, Sexual Function, Urethral and Bladder Wall Structure and Blood Flow in Women With Stress Urinary Incontinence: a Randomized Controlled Study
Duloxetine, Imipramine - Stress Urinary Incontinence
Phase 3WithdrawnFar Eastern Memorial Hospital2020-05-312022-08-17
Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)
Gefapixant, Placebo - Chronic Cough
Phase 3CompletedMerck Sharp & Dohme LLC3762020-05-102024-11-05
Vaginal Prolapse Surgery Accompanied by Mid Urethral Sling Versus no Sling for Reduction of Postoperative Incontinence
Retro pubic sling - Stress Urinary Incontinence, Vaginal Hysterectomy
Phase 2 / Phase 3UnknownB.P. Koirala Institute of Health Sciences562020-01-012020-02-05
tDCS and Female Urinary Incontinence
Real transcranial direct current stimulation + therapeutic exercises for urinary incontinence, Sham transcranial direct current stimulation + therapeutic exercises for urinary incontinence - Urinary Incontinence
Phase 2 / Phase 3CompletedUniversidade Federal do Piauí602019-11-142023-11-28
Chlorhexidine vs. Iodine for Vaginal Preparation in Urogynecologic Procedures
Vaginal scrub, to be applied vaginally and perineally immediately prior to surgery. - Pelvic Organ Prolapse, Urinary Incontinence
Phase 3CompletedUniversity of New Mexico1372019-07-152023-07-10
Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
AMDC-USR (iltamiocel), Placebo - Stress Urinary Incontinence
Phase 3Active not recruitingCook MyoSite962019-04-232026-10-21

Showing 20 of 133. Sign in to see all of them.

Narrower conditions

Urinary Incontinence, Stress (55)  ·  Urinary Bladder, Overactive (42)  ·  Urinary Incontinence, Urge (26)  ·  Urologic Diseases (8)  ·  Lower Urinary Tract Symptoms (6)  ·  Pelvic Organ Prolapse (6)  ·  Prostatic Neoplasms (5)  ·  Nocturia (4)  ·  Urinary Tract Infections (3)  ·  Nocturnal Enuresis (2)  ·  Parkinson Disease (2)  ·  Pelvic Floor Disorders (2)  ·  Urinary Bladder Diseases (2)  ·  Urinary Bladder, Neurogenic (2)

Broader conditions

Female Urogenital Diseases (133)  ·  Female Urogenital Diseases and Pregnancy Complications (133)  ·  Male Urogenital Diseases (133)  ·  Pathological Conditions, Signs and Symptoms (133)  ·  Urination Disorders (133)  ·  Urogenital Diseases (133)  ·  Urological Manifestations (133)  ·  Signs and Symptoms (132)  ·  Lower Urinary Tract Symptoms (127)  ·  Urologic Diseases (125)  ·  Urinary Bladder Diseases (41)  ·  Genital Diseases (10)  ·  Neoplasms by Site (7)  ·  Genital Diseases, Male (6)

Interventions

Botulinum Toxins, Type A (16)  ·  mirabegron (14)  ·  Duloxetine Hydrochloride (13)  ·  Tolterodine Tartrate (11)  ·  Solifenacin Succinate (10)  ·  oxybutynin (7)  ·  Suburethral Slings (5)  ·  propiverine (3)  ·  Behavior Therapy (2)  ·  Exercise Therapy (2)  ·  N-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carboxamide (2)  ·  Saline Solution (2)  ·  Surgical Procedures, Operative (2)  ·  abobotulinumtoxinA (2)  ·  ritobegron ethyl (2)

Sponsors

Eli Lilly and Company (12)  ·  Astellas Pharma Inc (7)  ·  Allergan (6)  ·  NICHD Pelvic Floor Disorders Network (5)  ·  Alza Corporation, DE, USA (4)  ·  Cook MyoSite (4)  ·  Copenhagen University Hospital at Herlev (4)  ·  University of Michigan (4)  ·  Hadassah Medical Organization (3)  ·  APOGEPHA Arzneimittel GmbH (2)  ·  Ain Shams University (2)  ·  Astellas Pharma Europe B.V. (2)  ·  Astellas Pharma Europe Ltd. (2)  ·  CHU de Quebec-Universite Laval (2)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)

Countries

United States (59)  ·  Canada (23)  ·  United Kingdom (21)  ·  Germany (17)  ·  Czechia (15)  ·  Italy (15)  ·  Poland (15)  ·  Belgium (14)  ·  Denmark (13)  ·  France (13)  ·  Russia (11)  ·  Spain (11)  ·  Finland (8)  ·  Hungary (8)  ·  Netherlands (8)

Top investigators

Melissa Kaufman, M.D., Ph.D. (3)  ·  Carolyn M Sampselle, PhD,RNC,FAAN (2)  ·  Linda Brubaker, MD (2)  ·  Matthew D Barber, MD, MHS (2)  ·  Mikkel Fode, MD (2)  ·  Yasuhiro Omori (2)

Results publications

PMID 37160401, PMID 37888839, PMID 24246044, PMID 32378735, PMID 37811598, PMID 21344495, PMID 33620895, PMID 35400537, PMID 10925088, PMID 11176403, PMID 11857671, PMID 12612489, PMID 12790869, PMID 12894267, PMID 12934777, PMID 14625427, PMID 14767293, PMID 15586150, PMID 16237512, PMID 16282227, PMID 16611949, PMID 16868693, PMID 16897749, PMID 17197581, PMID 17228060, PMID 17336819, PMID 17385940, PMID 18060963, PMID 18060965, PMID 18185903, PMID 18221532, PMID 18310363, PMID 18455536, PMID 18499184, PMID 18502028, PMID 18591307, PMID 18656053, PMID 18722933, PMID 18845288, PMID 18976976, PMID 19183825, PMID 19233423, PMID 19375574, PMID 19625327, PMID 19701041, PMID 19929591, PMID 19941278, PMID 20093904, PMID 20171668, PMID 20177294

NIH funding

U10HD041261 (3), U10HD041267 (3), 2015 (2), 2017 (2), R01NR007618 (2), U01HD069031 (2), U10HD041250 (2), U10HD041263 (2), U10HD054214 (2), U10HD054215 (2), 2008 (1), 2014 (1), 2019 (1), 2025 (1), R01NR004007 (1)